Prosecution Insights
Last updated: May 29, 2026

Examiner: MEYERS, ELIZABETH ANNE

Tech Center 1600 • Art Units: 1617

This examiner grants 23% of resolved cases

Performance Statistics

23.1%
Allow Rate
-36.9% vs TC avg
73
Total Applications
+100.0%
Interview Lift
1099
Avg Prosecution Days
Based on 13 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
1.3%
§102 Novelty
56.9%
§103 Obviousness
0.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18688943 AN ORAL CARE COMPOSITION COMPRISING A GLYCOLIPID AND A MILD SURFACTANT Final Rejection BASF SE
17872294 METHODS AND MATERIALS FOR TREATING HYPOCAPNIA Non-Final OA Mayo Foundation for Medical Education and Research
17795099 SUSTAINED-RELEASE MATRICES FOR ADVENTITIAL OR PERIADVENTITIAL NEURAL ABLATION AND USES THEREOF Non-Final OA W. L. Gore & Associates, Inc.
18278903 MICRONEEDLES AND METHODS FOR TREATING THE SKIN Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
18248235 AGRICULTURAL BIOPOLYMER COATING PLATFORM Final Rejection AgroSpheres, Inc.
18552540 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS Final Rejection L'OREAL
18231735 COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS Final Rejection L'Oreal
18265540 COMPOSITION FOR CLEANSING KERATIN MATERIALS Final Rejection L'OREAL
18255830 ANHYDROUS SOLID SHAMPOO BASED ON SURFACTANTS AND ON A FATTY ACID SALT, ITS METHOD OF PREPARATION AND A KIT Final Rejection L'OREAL
18115247 COMPOSITIONS AND METHODS FOR CURLY HAIR Final Rejection L'Oreal
17756872 DIETARY BUTYRATE AND ITS USES Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
17595855 Surface Modified Gas Vesicles, Preparation and Applications thereof Final Rejection THE HONG KONG POLYTECHNIC UNIVERSITY
18688180 COMPOSITIONS AND METHODS FOR TREATING BONE INJURIES Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17777102 INCLUSION COMPLEXES OF PHARMACEUTICALS AND CYCLIC OLIGOMERS Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18580076 COMPOSITIONS WITH MICROENCAPSULATED ACETAMIDE AND METAL-CHELATED MESOTRIONE Non-Final OA MONSANTO TECHNOLOGY LLC
18255080 PESTICIDAL COMPOSITION Final Rejection SUMITOMO CHEMICAL COMPANY, LIMITED
18226832 NANO-SILICA - IN YEAST PARTICLE (YP) DRUG ENCAPSULATION APPROACH FOR IMPROVED THERMAL AND HYDROLASE STABILITY OF YP DRUG DELIVERY FORMULATIONS Final Rejection UNIVERSITY OF MASSACHUSETTS
18073969 MULTILEVEL ANTIMICROBIAL POLYMERIC COLLOIDS AND DEVICE SCREENS CONTAINING SAME Non-Final OA THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
18009324 Compositions Comprising One or More (Bio)-Alkanediols with Active Ingredients Final Rejection Symrise AG
18714108 HAIR CARE COMPOSITION Non-Final OA Conopco, Inc., d/b/a UNILEVER
17779865 METHODS OF USING SOLUBLE SOLID DISPERSIONS OF RIFAXIMIN Non-Final OA United States Government as Represented by the Department of Veterans Affairs
17639699 Cosmetic Composition Comprising Solid Phase Polymer Components Having Improved Solubility Non-Final OA LG Household & Health Care Ltd.
18001738 FRAGRANCE-STABLE COSMETIC PREPARATION Non-Final OA BEIERSDORF AG
18686139 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID Non-Final OA LTS LOHMANN THERAPIE-SYSTEME AG
18272391 ORAL THIN FILM Final Rejection LTS Lohmann Therapie-Systeme AG
18272205 ORAL THIN FILMS Final Rejection LTS LOHMANN THERAPIE-SYSTEME AG
18268462 AQUEOUS EMULSION Final Rejection L V M H RECHERCHE
18254444 LIQUID AGROCHEMICAL COMPOSITION Final Rejection NOURYON CHEMICALS INTERNATIONAL B.V.
18390119 ROSEWOOD ESSENTIAL OIL NANOCAPSULES AND THEIR NANOENCAPSULATION PROCESS Non-Final OA Instituto Nacional de Pesquisas da Amazônia (INPA)
18570372 MICELLAR SOLUTION COMPRISING DICLOFENAC Non-Final OA GSK CONSUMER HEALTHCARE SARL

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month